22157.jpg
Pulmonary Fibrosis Treatment Market Research: Escalating Demand for Innovative Treatment Options Amidst Escalating Prevalence - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031
May 24, 2024 03:29 ET | Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Pulmonary Fibrosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
22157.jpg
Pulmonary Fibrosis Pipeline Insights Report, 2024: Analyzing the Evolving Landscape of Pulmonary Fibrosis Clinical Development and Market Growth
April 16, 2024 09:22 ET | Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Pulmonary Fibrosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report outlays comprehensive...
22157.jpg
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
April 08, 2024 09:20 ET | Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report...
22157.jpg
Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2024-2034: IPF Industry to Observe Robust Expansion with Emerging Therapies and Increasing Prevalence of Cough-Related IPF
January 25, 2024 07:29 ET | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cough in Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034" report has been added to ...
Idiopathic Pulmonary Fibrosis Treatment Market
Leading Companies like Roche and Novartis at the Helm of the Global Rapidly Expanding IPF Treatment Market to 2030
September 26, 2023 05:23 ET | Research and Markets
Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ...
Idiopathic Pulmonary Fibrosis Market
Global Idiopathic Pulmonary Fibrosis Market Report 2023: Sector is Expected to Reach $7.52 Billion by 2030 at a CAGR of 8.7%
June 15, 2023 08:03 ET | Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market, By Drug, By Route of Administration, By Distribution Channel, and By Geography - Size, Share, Outlook, and...
22157.jpg
Europe Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, Shionogi & Co, AstraZeneca & Others
August 11, 2022 05:03 ET | Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Europe Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
22157.jpg
LAMEA Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, AstraZeneca, Bristol Myers Squibb & Others
August 04, 2022 04:38 ET | Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
22157.jpg
Global Idiopathic Pulmonary Fibrosis Disease Treatment Markets, 2018-2019 & 2020-2024
September 08, 2021 03:58 ET | Research and Markets
Dublin, Sept. 08, 2021 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Disease Treatment: Global Markets" report has been added to ResearchAndMarkets.com's offering.The current report...